On Invalid Date, Burning Rock Biotech (NASDAQ: BNR) reported Q2 2023 earnings per share (EPS) of -$0.18, up 52.55% year over year. Total Burning Rock Biotech earnings for the quarter were -$18.13 million. In the same quarter last year, Burning Rock Biotech's earnings per share (EPS) was -$0.37.
As of Q3 2023, Burning Rock Biotech's earnings has grown year over year. Burning Rock Biotech's earnings in the past year totalled -$105.26 million.
What is BNR's earnings date?
Burning Rock Biotech's earnings date is Invalid Date. Add BNR to your watchlist to be reminded of BNR's next earnings announcement.
What was BNR's revenue last quarter?
On Invalid Date, Burning Rock Biotech (NASDAQ: BNR) reported Q2 2023 revenue of $20.20 million up 3.45% year over year. In the same quarter last year, Burning Rock Biotech's revenue was $19.53 million.
What was BNR's revenue growth in the past year?
As of Q3 2023, Burning Rock Biotech's revenue has grown 0.3% year over year. This is 1.61 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 1.91%. Burning Rock Biotech's revenue in the past year totalled $80.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.